tiprankstipranks
Advertisement
Advertisement

MGNX Stock Latest News

MacroGenics upgraded to Buy at B. Riley after deal for Tubulus
The FlyMacroGenics upgraded to Buy at B. Riley after deal for Tubulus
8d ago
GILD
MGNX
MacroGenics upgraded to Buy from Neutral at B. Riley
PremiumThe Fly
MacroGenics upgraded to Buy from Neutral at B. Riley
8d ago
MGNX
MacroGenics Resumes LINNET Trial After FDA Hold Lifted
PremiumCompany Announcements
MacroGenics Resumes LINNET Trial After FDA Hold Lifted
10d ago
8K
MGNX
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
PremiumThe Fly
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
10d ago
MGNX
MacroGenics price target raised to $4 from $3 at Barclays
PremiumThe Fly
MacroGenics price target raised to $4 from $3 at Barclays
1M ago
MGNX
FDA Places Partial Clinical Hold on MacroGenics Trial
PremiumCompany AnnouncementsFDA Places Partial Clinical Hold on MacroGenics Trial
2M ago
8K
MGNX
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
Premium
The Fly
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
2M ago
MGNX
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
2M ago
MGNX
MacroGenics Announces Departure of Chief Medical Officer
PremiumCompany Announcements
MacroGenics Announces Departure of Chief Medical Officer
5M ago
8K
MGNX
MacroGenics, Inc. Reports Decline in Quarterly Revenues
PremiumCompany Announcements
MacroGenics, Inc. Reports Decline in Quarterly Revenues
5M ago
MGNX
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
PremiumRatings
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
5M ago
MGNX
MacroGenics reports Q3 EPS 27c vs 90c last year
PremiumThe Fly
MacroGenics reports Q3 EPS 27c vs 90c last year
5M ago
MGNX
MacroGenics expects cash to fund operations into late 2027
PremiumThe FlyMacroGenics expects cash to fund operations into late 2027
5M ago
MGNX
MGNX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MGNX Earnings this Week: How Will it Perform?
5M ago
MGNX
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
Premium
Company Announcements
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
6M ago
MGNX
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
6M ago
MGNX
MacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
PremiumCompany Announcements
MacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
6M ago
MGNX
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
6M ago
MGNX
MacroGenics assumed with an Overweight at Barclays
PremiumThe Fly
MacroGenics assumed with an Overweight at Barclays
7M ago
MGNX
MacroGenics initiated with an Overweight at Barclays
PremiumThe FlyMacroGenics initiated with an Overweight at Barclays
7M ago
MGNX
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
Premium
Ratings
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
8M ago
MGNX
MacroGenics price target lowered to $5 from $8 at Leerink
Premium
The Fly
MacroGenics price target lowered to $5 from $8 at Leerink
8M ago
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >